Strs Ohio raised its stake in Bruker Co. (NASDAQ:BRKR) by 6.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,148 shares of the medical research company’s stock after acquiring an additional 591 shares during the period. Strs Ohio’s holdings in Bruker were worth $302,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in BRKR. Bank of Montreal Can grew its position in Bruker by 1,244.3% during the third quarter. Bank of Montreal Can now owns 64,753 shares of the medical research company’s stock valued at $2,166,000 after buying an additional 59,936 shares during the period. Scout Investments Inc. grew its position in shares of Bruker by 2.1% in the third quarter. Scout Investments Inc. now owns 192,856 shares of the medical research company’s stock valued at $6,451,000 after purchasing an additional 4,040 shares during the period. First Hawaiian Bank acquired a new stake in shares of Bruker in the third quarter valued at about $248,000. Nisa Investment Advisors LLC acquired a new stake in shares of Bruker in the third quarter valued at about $432,000. Finally, Seven Eight Capital LP acquired a new stake in shares of Bruker in the third quarter valued at about $445,000. Hedge funds and other institutional investors own 64.67% of the company’s stock.
Shares of NASDAQ BRKR opened at $37.27 on Friday. The company has a current ratio of 2.24, a quick ratio of 1.32 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $5.87 billion, a PE ratio of 26.62, a P/E/G ratio of 2.05 and a beta of 1.49. Bruker Co. has a 52-week low of $26.10 and a 52-week high of $38.04.
Several analysts have recently issued reports on BRKR shares. BidaskClub upgraded shares of Bruker from a “hold” rating to a “buy” rating in a research report on Wednesday, November 7th. ValuEngine upgraded shares of Bruker from a “hold” rating to a “buy” rating in a research report on Thursday, November 8th. Zacks Investment Research upgraded shares of Bruker from a “hold” rating to a “strong-buy” rating and set a $38.00 target price on the stock in a research report on Monday, November 12th. Needham & Company LLC started coverage on shares of Bruker in a research report on Wednesday, January 2nd. They issued a “strong-buy” rating and a $39.00 target price on the stock. Finally, BTIG Research reiterated a “buy” rating and issued a $44.00 target price (up previously from $42.00) on shares of Bruker in a research report on Tuesday. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $36.17.
COPYRIGHT VIOLATION NOTICE: This report was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://sportsperspectives.com/2019/02/15/strs-ohio-has-302000-holdings-in-bruker-co-brkr.html.
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
Featured Story: Cash Flow
Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKR).
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.